Global Injection Botulinum Toxin Type A Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Injection Botulinum Toxin Type A Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Botox is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis.
Injection Botulinum Toxin Type A report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Injection Botulinum Toxin Type A market is projected to reach US$ 971.7 million in 2029, increasing from US$ 652 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2029. Demand from Medical and Cosmetic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Injection Botulinum Toxin Type A industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Injection Botulinum Toxin Type A key manufacturers include Allergan, Ipsen, Medytox, LIBP, Merz Pharmaceuticals, Hugel and Daewoong, etc. Allergan, Ipsen, Medytox are top 3 players and held % sales share in total in 2022.
Injection Botulinum Toxin Type A can be divided into 50U, 100U and Others,, etc. 50U is the mainstream product in the market, accounting for % sales share globally in 2022.
Injection Botulinum Toxin Type A is widely used in various fields, such as Medical and Cosmetic, etc. Medical provides greatest supports to the Injection Botulinum Toxin Type A industry development. In 2022, global % sales of Injection Botulinum Toxin Type A went into Medical filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Injection Botulinum Toxin Type A market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Allergan
Ipsen
Medytox
LIBP
Merz Pharmaceuticals
Hugel
Daewoong
Segment by Type
50U
100U
Others
Medical
Cosmetic
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Injection Botulinum Toxin Type A market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Injection Botulinum Toxin Type A, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Injection Botulinum Toxin Type A industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Injection Botulinum Toxin Type A in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Injection Botulinum Toxin Type A introduction, etc. Injection Botulinum Toxin Type A Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Injection Botulinum Toxin Type A market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Injection Botulinum Toxin Type A report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Injection Botulinum Toxin Type A market is projected to reach US$ 971.7 million in 2029, increasing from US$ 652 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2029. Demand from Medical and Cosmetic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Injection Botulinum Toxin Type A industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Injection Botulinum Toxin Type A key manufacturers include Allergan, Ipsen, Medytox, LIBP, Merz Pharmaceuticals, Hugel and Daewoong, etc. Allergan, Ipsen, Medytox are top 3 players and held % sales share in total in 2022.
Injection Botulinum Toxin Type A can be divided into 50U, 100U and Others,, etc. 50U is the mainstream product in the market, accounting for % sales share globally in 2022.
Injection Botulinum Toxin Type A is widely used in various fields, such as Medical and Cosmetic, etc. Medical provides greatest supports to the Injection Botulinum Toxin Type A industry development. In 2022, global % sales of Injection Botulinum Toxin Type A went into Medical filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Injection Botulinum Toxin Type A market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Allergan
Ipsen
Medytox
LIBP
Merz Pharmaceuticals
Hugel
Daewoong
Segment by Type
50U
100U
Others
Segment by Application
Medical
Cosmetic
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Injection Botulinum Toxin Type A market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Injection Botulinum Toxin Type A, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Injection Botulinum Toxin Type A industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Injection Botulinum Toxin Type A in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Injection Botulinum Toxin Type A introduction, etc. Injection Botulinum Toxin Type A Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Injection Botulinum Toxin Type A market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices